Answer :
Metoclopramide is a prokinetic drug that improves gastrointestinal motility. The nurse should provide the metoclopramide and alert the client's health care physician about the involuntary finger movement.
The client may be suffering from tardive dyskinesia, a significant adverse effect of long-term metoclopramide treatment. Involuntary movements of the face, arms, and legs are signs and symptoms of tardive dyskinesia.
What is the use of Metoclopramide?
Metoclopramide acts by antagonizing central and peripheral dopamine-two receptors in the postrema medullary chemoreceptor trigger zone, which is normally triggered by levodopa or apomorphine.
- It accomplishes this by lowering the sensitivity of visceral afferent neurons that communicate from the gastrointestinal system to the vomiting centre in the chemoreceptor trigger zone in the region postrema.
- Metoclopramide also inhibits apomorphine's antiperistaltic effects, allowing it to decrease apomorphine's inhibition of gastric emptying and hence accelerate gastric emptying by increasing the amplitude and duration of oesophagal contractions.
- This also increases the lower oesophagal sphincter's resting tone while relaxing the duodenal bulb and pyloric sphincter, enhancing peristalsis in the duodenum and jejunum.
Learn more about metoclopramide here,
https://brainly.com/question/3197821
# SPJ4
The prescription that the nurse requested clarification from the health care provider was an IV dose of 10 mg of metoclopramide recommended for a patient who frequently had involuntary finger movements.
Metoclopramide functions by antagonising central and peripheral dopamine-two receptors in the postrema medullary chemoreceptor trigger zone, which is generally triggered by levodopa or apomorphine. It accomplishes this by reducing the sensitivity of visceral afferent neurons that communicate from the gastrointestinal system to the vomiting centre in the chemoreceptor trigger zone in the area postrema.
Apocomorphine's antiperistaltic effects are likewise inhibited by metoclopramide, which enables it to lessen the inhibition of gastric emptying caused by apomorphine and, as a result, speeds up stomach emptying by increasing the amplitude and length of oesophageal contractions. This improves peristalsis in the duodenum and jejunum while raising the resting tone of the lower oesophageal sphincter and relaxing the pyloric and duodenal sphincters.
Learn more about metoclopramide here,
brainly.com/question/3197821
# SPJ4
